Search
for
Sort by
Research 31–60 of 31
- ZALCITABINE
- Alopecia induced by dopamine agonists
- Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease
- Mutation in 5′ upstream region of <i>GCH</i> I gene causes familial dopa-responsive dystonia
- Prednisolone
- Pramipexole
- Drug Reactions Affecting Hair: Diagnosis
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Parkinson's disease and skin
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine
- Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Chemically Induced Hair Loss/Alopecia
- Drugs that affect autonomic functions or the extrapyramidal system
- Finasteride appears to be associated with an increased incidence of sexual dysfunction
- Hair loss, old and uninterested nonmotor symptom in Parkinson’s disease during dopaminergic therapy
- WARFARIN
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Electroosmotic pore transport in human skin.
- An overview of current strategies and future prospects in drug repurposing in tuberculosis
- Combined drug triads for synergic neuroprotection in retinal degeneration
- Nanoemulgel: For Promising Topical and Systemic Delivery
- <i>Nigella sativa</i> and its nano‐mediated approach toward management of neurodegenerative disorders: A review
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system